Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank86
5Y CAGR+25.9%
Year-over-Year Change
Debt-to-equity ratio
5Y CAGR
+25.9%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.62 | -96.0% |
| 2024 | 40.89 | +791.2% |
| 2023 | -5.92 | +29.1% |
| 2022 | -8.34 | -592.0% |
| 2021 | 1.70 | +230.7% |
| 2020 | 0.51 | +142.9% |
| 2019 | 0.21 | +816.5% |
| 2018 | 0.02 | +35.7% |
| 2017 | 0.02 | -89.6% |
| 2016 | 0.16 | - |